PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
350.00%
Net income growth above 1.5x MCHP's 6.32%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-1.41%
Both reduce yoy D&A, with MCHP at -1.71%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-152.94%
Negative yoy deferred tax while MCHP stands at 331.77%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
No Data
No Data available this quarter, please select a different quarter.
-25.20%
Negative yoy working capital usage while MCHP is 22.95%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-205.88%
Negative yoy inventory while MCHP is 65.86%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
No Data
No Data available this quarter, please select a different quarter.
2.73%
Lower 'other working capital' growth vs. MCHP's 20.90%. David Dodd would see fewer unexpected short-term demands on cash.
115.79%
Well above MCHP's 114.11%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
30.74%
Operating cash flow growth below 50% of MCHP's 136.89%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-47.50%
Both yoy lines negative, with MCHP at -40.86%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
11.20%
Purchases growth of 11.20% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
35.70%
Liquidation growth of 35.70% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
No Data
No Data available this quarter, please select a different quarter.
67.90%
We have mild expansions while MCHP is negative at -48.80%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
183.33%
Stock issuance far above MCHP's 181.75%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
-138.10%
We cut yoy buybacks while MCHP is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.